Exact Mass: 364.0339

Exact Mass Matches: 364.0339

Found 59 metabolites which its exact mass value is equals to given mass value 364.0339, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

6-Thioinosine-5'-monophosphate

{[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-sulfanyl-9H-purin-9-yl)oxolan-2-yl]methoxy}phosphonic acid

C10H13N4O7PS (364.0243)


6-Thioinosine-5-monophosphate is a metabolite of mercaptopurine. Mercaptopurine (also called 6-mercaptopurine, 6-MP or its brand name Purinethol) is an immunosuppressive drug. It is a thiopurine. (Wikipedia)

   

Xanthylic acid

{[(2R,3S,4R,5R)-5-(2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H13N4O9P (364.042)


Xanthylic acid, also known as xmp or (9-D-ribosylxanthine)-5-phosphate, is a member of the class of compounds known as purine ribonucleoside monophosphates. Purine ribonucleoside monophosphates are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Xanthylic acid is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Xanthylic acid can be found in a number of food items such as common grape, black-eyed pea, java plum, and wild rice, which makes xanthylic acid a potential biomarker for the consumption of these food products. Xanthylic acid exists in all living species, ranging from bacteria to humans. In humans, xanthylic acid is involved in several metabolic pathways, some of which include azathioprine action pathway, glutamate metabolism, mercaptopurine action pathway, and purine metabolism. Xanthylic acid is also involved in several metabolic disorders, some of which include purine nucleoside phosphorylase deficiency, succinic semialdehyde dehydrogenase deficiency, xanthine dehydrogenase deficiency (xanthinuria), and molybdenum cofactor deficiency. Xanthosine monophosphate is an intermediate in purine metabolism. It is a ribonucleoside monophosphate. It is formed from IMP via the action of IMP dehydrogenase, and it forms GMP via the action of GMP synthaseand is) also, XMP can be released from XTP by enzyme deoxyribonucleoside triphosphate pyrophosphohydrolase containing (d)XTPase activity . Xanthylic acid is an important metabolic intermediate in the Purine Metabolism, and is a product or substrate of the enzymes Inosine monophosphate dehydrogenase (EC 1.1.1.205), Hypoxanthine phosphoribosyltransferase (EC 2.4.2.8), Xanthine phosphoribosyltransferase (EC 2.4.2.22), 5-Ribonucleotide phosphohydrolase (EC 3.1.3.5), Ap4A hydrolase (EC 3.6.1.17), Nucleoside-triphosphate diphosphatase (EC 3.6.1.19), Phosphoribosylamine-glycine ligase (EC 6.3.4.1), and glutamine amidotransferase (EC 6.3.5.2). (KEGG) Xanthylic acid can also be used in quantitative measurements of the Inosine monophosphate dehydrogenase enzyme activities in purine metabolism. This measurement is important for optimal thiopurine therapy for children with acute lymphoblastic leukaemia (ALL). (PMID: 16725387). Acquisition and generation of the data is financially supported in part by CREST/JST. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Fertilysin

Fertilysin

C12H20Cl4N2O2 (364.0279)


Win 18446 is an orally active testes-specific enzyme ALDH1a2 inhibitor, with an IC50 of 0.3 μM. Win 18446 reversibly inhibits spermatogenesis in many species and inhibits Retinoic acid (HY-14649) biosynthesis from Retinol (HY-B1342) within the testes[1][2].

   

5'-xanthylate(2-)

{[5-(2,6-dihydroxy-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H13N4O9P (364.042)


5-xanthylate(2-) is also known as 5-Xanthylate dianion or XMP. 5-xanthylate(2-) is considered to be slightly soluble (in water) and acidic

   

Biochanin a 7-sulfate

[5-Hydroxy-3-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl]oxidanesulphonic acid

C16H12O8S (364.0253)


   

Fertilysin

2,2-dichloro-N-[8-(2,2-dichloroacetamido)octyl]acetamide

C12H20Cl4N2O2 (364.0279)


Win 18446 is an orally active testes-specific enzyme ALDH1a2 inhibitor, with an IC50 of 0.3 μM. Win 18446 reversibly inhibits spermatogenesis in many species and inhibits Retinoic acid (HY-14649) biosynthesis from Retinol (HY-B1342) within the testes[1][2].

   

Indacrinone

2-[(6,7-dichloro-2-methyl-1-oxo-2-phenyl-2,3-dihydro-1H-inden-5-yl)oxy]acetic acid

C18H14Cl2O4 (364.0269)


D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49184 - Loop Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

   

thioinosine monophosphate

{[3-hydroxy-5-(6-oxo-6,9-dihydro-1H-purin-9-yl)-4-sulfanyloxolan-2-yl]methoxy}phosphonic acid

C10H13N4O7PS (364.0243)


   

(-)-Maackiain 3-sulfate

(-)-Maackiain 3-sulfate

C16H12O8S (364.0253)


   
   
   

((2R,3R,4S,5R)-5-(2,6-dioxo-1,2,3,6-tetrahydropurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl)methyl hydrogen sulfate

((2R,3R,4S,5R)-5-(2,6-dioxo-1,2,3,6-tetrahydropurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl)methyl hydrogen sulfate

C10H12N4O9S (364.0325)


   

dehydropicrorhiza acid methyl diester

dehydropicrorhiza acid methyl diester

C16H12O10 (364.043)


   

Antibiotic SS 19508B

Antibiotic SS 19508B

C17H13ClO7 (364.035)


   

2-chloro-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylic acid methyl ester|3-Dechlor-lecideoidin|3-Dechlorolecideoidin|dechlorolecideoidin

2-chloro-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylic acid methyl ester|3-Dechlor-lecideoidin|3-Dechlorolecideoidin|dechlorolecideoidin

C17H13ClO7 (364.035)


   
   

2,4,5-trihydroxy-3-(4,6,7-trihydroxy-3-oxo-1,3-dihydroisobenzofuran-5-yl)-benzoic acid methyl ester

2,4,5-trihydroxy-3-(4,6,7-trihydroxy-3-oxo-1,3-dihydroisobenzofuran-5-yl)-benzoic acid methyl ester

C16H12O10 (364.043)


   

Niruriflavone

Niruriflavone

C16H12O8S (364.0253)


   

Thioinosinic acid

Thioinosinic acid

C10H13N4O7PS (364.0243)


[Raw Data] CB244_Thioinosinic-acid_pos_50eV_CB000084.txt [Raw Data] CB244_Thioinosinic-acid_pos_40eV_CB000084.txt [Raw Data] CB244_Thioinosinic-acid_pos_30eV_CB000084.txt [Raw Data] CB244_Thioinosinic-acid_pos_20eV_CB000084.txt [Raw Data] CB244_Thioinosinic-acid_pos_10eV_CB000084.txt

   

Xanthosine 5-monophosphate

Xanthosine 5-monophosphate

C10H13N4O9P (364.042)


   

Xanthosine-5′-monophosphate disodium salt

Xanthosine-5′-monophosphate disodium salt

C10H13N4O9P (364.042)


   

XANTHOSINE 5'-MONOPHOSPHATE

XANTHOSINE 5'-MONOPHOSPHATE

C10H13N4O9P (364.042)


   

XANTHOSINE-MONOPHOSPHATE

XANTHOSINE-MONOPHOSPHATE

C10H13N4O9P (364.042)


   

Oxipurinol-7-ribonucleotide

Oxipurinol-7-ribonucleotide

C10H13N4O9P (364.042)


   

methyl 5-chloro-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridine-3-carboxylate

methyl 5-chloro-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridine-3-carboxylate

C16H13ClN2O4S (364.0285)


   

5,6-Dichloro-1-ethyl-2-methyl-3-(3-sulfobutyl)benzimidazolium inner salt

5,6-Dichloro-1-ethyl-2-methyl-3-(3-sulfobutyl)benzimidazolium inner salt

C14H18Cl2N2O3S (364.0415)


   

Suclofenide

Suclofenide

C16H13ClN2O4S (364.0285)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent

   

3-(1-NAPHTHALENYLOXY)-1,2-CYCLOPROPANE

3-(1-NAPHTHALENYLOXY)-1,2-CYCLOPROPANE

C12H17IN2O3 (364.0284)


   

LANTHANUM (III) 2-METHOXYETHOXIDE

LANTHANUM (III) 2-METHOXYETHOXIDE

C9H21LaO6 (364.0402)


   

ethyl 7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,8-naphthyridine-3-carboxylate

ethyl 7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,8-naphthyridine-3-carboxylate

C17H11ClF2N2O3 (364.0426)


   

Sodium Diphenylphosphinobenzene-3-Sulfonate

Sodium Diphenylphosphinobenzene-3-Sulfonate

C18H14NaO3PS (364.0299)


   

5-(4-CYANO-BENZOYLAMINO)-2-ETHOXY-BENZENESULFONYL CHLORIDE

5-(4-CYANO-BENZOYLAMINO)-2-ETHOXY-BENZENESULFONYL CHLORIDE

C16H13ClN2O4S (364.0285)


   

4-chloro-N-[3-cyano-4-(phenylthio)phenyl]benzamide

4-chloro-N-[3-cyano-4-(phenylthio)phenyl]benzamide

C20H13ClN2OS (364.0437)


   

5-(4-Bromophenyl)-2-phenylpyrazolo[1,5-a]pyrimidin-7-amine

5-(4-Bromophenyl)-2-phenylpyrazolo[1,5-a]pyrimidin-7-amine

C18H13BrN4 (364.0324)


   

4-[1-[(3,4-Dichlorophenyl)methylamino]propylidene]-2-(2-furanyl)-5-oxazolone

4-[1-[(3,4-Dichlorophenyl)methylamino]propylidene]-2-(2-furanyl)-5-oxazolone

C17H14Cl2N2O3 (364.0381)


   
   

Indacrinone

Indacrinone

C18H14Cl2O4 (364.0269)


D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49184 - Loop Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

   

5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-)

5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-)

C10H13N4O9P-2 (364.042)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

[3-hydroxy-5-(6-oxo-1H-purin-9-yl)-4-sulfanyloxolan-2-yl]methyl dihydrogen phosphate

[3-hydroxy-5-(6-oxo-1H-purin-9-yl)-4-sulfanyloxolan-2-yl]methyl dihydrogen phosphate

C10H13N4O7PS (364.0243)


   

Biochanin a 7-sulfate

Biochanin a 7-sulfate

C16H12O8S (364.0253)


   

1-(4-Bromophenyl)-3-[2-(2-methoxyphenoxy)ethyl]urea

1-(4-Bromophenyl)-3-[2-(2-methoxyphenoxy)ethyl]urea

C16H17BrN2O3 (364.0422)


   

3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide

3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide

C15H13ClN4O3S (364.0397)


   

4-(4-Bromophenyl)-2-(3,5-dimethyl-1-pyrazolyl)-4-oxobutanoic acid methyl ester

4-(4-Bromophenyl)-2-(3,5-dimethyl-1-pyrazolyl)-4-oxobutanoic acid methyl ester

C16H17BrN2O3 (364.0422)


   

2-Chloro-5-[[[[(3-methoxyphenyl)-oxomethyl]amino]-sulfanylidenemethyl]amino]benzoic acid

2-Chloro-5-[[[[(3-methoxyphenyl)-oxomethyl]amino]-sulfanylidenemethyl]amino]benzoic acid

C16H13ClN2O4S (364.0285)


   

[5-(7-Hydroxy-4-oxochromen-2-yl)-2-methoxyphenyl] hydrogen sulate

[5-(7-Hydroxy-4-oxochromen-2-yl)-2-methoxyphenyl] hydrogen sulate

C16H12O8S (364.0253)


   

5-xanthylic acid

Xanthosine-5-monophosphate

C10H13N4O9P (364.042)


A purine ribonucleoside 5-monophosphate having xanthine as the nucleobase. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-)

5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-)

C10H13N4O9P (364.042)


Dianion of 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide.

   

VPC-70619

VPC-70619

C16H8ClF3N4O (364.0339)


VPC-70619 is a potent, orally active N-Myc inhibitor. VPC-70619 blocks the N-Myc-Max heterocomplex from binding to DNA E-boxes and demonstrated strong inhibition activity against N-Myc-dependent cell lines as well as high bioavailability in both oral and intraperitoneal administration[1].

   

glycitein sulfate

new_metabolite-214768

C16H12O8S (364.0253)


new metabolite created

   

(8-hydroxy-6-methoxy-3-methyl-9,10-dioxoanthracen-2-yl)oxidanesulfonic acid

(8-hydroxy-6-methoxy-3-methyl-9,10-dioxoanthracen-2-yl)oxidanesulfonic acid

C16H12O8S (364.0253)


   

methyl 1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracene-9-carboxylate

methyl 1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracene-9-carboxylate

C16H12O10 (364.043)


   

methyl 2,4,5-trihydroxy-3-(4,6,7-trihydroxy-3-oxo-1h-2-benzofuran-5-yl)benzoate

methyl 2,4,5-trihydroxy-3-(4,6,7-trihydroxy-3-oxo-1h-2-benzofuran-5-yl)benzoate

C16H12O10 (364.043)


   

5,7,11,19-tetraoxapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13,15,17-hexaen-16-yloxidanesulfonic acid

5,7,11,19-tetraoxapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13,15,17-hexaen-16-yloxidanesulfonic acid

C16H12O8S (364.0253)


   

(1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracen-9-yl)acetic acid

(1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracen-9-yl)acetic acid

C16H12O10 (364.043)


   

[(9s)-1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracen-9-yl]acetic acid

[(9s)-1,2,3,4,6,7,8-heptahydroxy-10-oxo-9h-anthracen-9-yl]acetic acid

C16H12O10 (364.043)


   

[(2s,3s,4s,5s)-5-(2,6-dihydroxypurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxyphosphonic acid

[(2s,3s,4s,5s)-5-(2,6-dihydroxypurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxyphosphonic acid

C10H13N4O9P (364.042)


   

5,7-dihydroxy-2-(4-methoxyphenyl)-4-oxochromene-6-sulfonic acid

5,7-dihydroxy-2-(4-methoxyphenyl)-4-oxochromene-6-sulfonic acid

C16H12O8S (364.0253)


   

poly(xanthylic acid)

poly(xanthylic acid)

C10H13N4O9P (364.042)


   

(1r,12r)-5,7,11,19-tetraoxapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13,15,17-hexaen-16-yloxidanesulfonic acid

(1r,12r)-5,7,11,19-tetraoxapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13,15,17-hexaen-16-yloxidanesulfonic acid

C16H12O8S (364.0253)